Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure

This study has been withdrawn prior to enrollment.
(Study was cancelled before enrolment for reasons not related to vaccine safety or efficacy.)
United States Department of Health and Human Services, Center for Disease Control and Prevention, National Institutes of Health, Department of Defense
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: January 7, 2010
Last updated: March 19, 2015
Last verified: March 2015
No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: February 2013
  Estimated Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)